Credo Diagnostics nabs CE mark for VitaPCR™ Flu A/B and VitaPCR™ RSV external control sets
Taiwan, January 10, 2022 –Credo Diagnostics Biomedical Pte. Ltd. is delighted to announce that both VitaPCR™ Flu A/B and VitaPCR™ RSV external control sets have obtained the CE IVD mark. These control sets are intended to be used for quality control testing with a series of VitaPCR™ Assays (exclude VitaPCR™ SARS-CoV-2 Assay, Cat# PCRAE0114) VitaPCR™ […]
